DEPARTMENT OF NEUROLOGY OSMANIA MEDICAL COLLEGE Dr kiran

  • Slides: 92
Download presentation
DEPARTMENT OF NEUROLOGY OSMANIA MEDICAL COLLEGE Dr kiran Resident in Neurology

DEPARTMENT OF NEUROLOGY OSMANIA MEDICAL COLLEGE Dr kiran Resident in Neurology

American Academy of Neurology Guideline Update 2010 Determining BRAIN DEATH in Adult

American Academy of Neurology Guideline Update 2010 Determining BRAIN DEATH in Adult

 Coma, from the Greek ‘‘deep sleep or trance, ’’ is a state of

Coma, from the Greek ‘‘deep sleep or trance, ’’ is a state of unresponsiveness in which the patient lies with eyes closed and cannot be aroused to respond appropriately to stimuli even with vigorous stimulation.

 • Three medical considerations emphasize the importance of the concept of brain death:

• Three medical considerations emphasize the importance of the concept of brain death: (1) Transplant programs require the donation of healthy peripheral organs for success. The early diagnosis of brain death before the systemic circulation fails allows the salvage of such organs. However, ethical and legal considerations demand that if one is to declare the brain dead, the criteria must be clear and unassailable

(2) Even if there were no transplant programs, the ability of modern medicine to

(2) Even if there were no transplant programs, the ability of modern medicine to keep a body functioning for extended periods often leads to prolonged, expensive, and futile procedures accompanied by great emotional strain on family and medical staff.

(3) Critical care facilities; are limited and expensive and inevitably place a drain on

(3) Critical care facilities; are limited and expensive and inevitably place a drain on other medical resources. Their best use demands that one identify and select patients who are most likely to benefit from intensive techniques, so that these units are not overloaded with individuals who can never recover cerebral function.

 The THREE clinical findings necessary to confirm irreversible cessation of all functions of

The THREE clinical findings necessary to confirm irreversible cessation of all functions of the entire brain, including the brain stem: 1. coma (with a known cause) 2. absence of brainstem reflexes, and 3. apnea.

4 Steps in Determining Brain Death The Clinical Evaluation The Neurologic Assessment Ancillary Test

4 Steps in Determining Brain Death The Clinical Evaluation The Neurologic Assessment Ancillary Test Documentation

The Clinical Evaluation A. Establish irreversible and proximate cause of coma. Exclude the presence

The Clinical Evaluation A. Establish irreversible and proximate cause of coma. Exclude the presence of a CNS-depressant drug effect There should be no recent administration or continued presence of neuromuscular blocking agents There should be no severe electrolyte, acid-base, or endocrine disturbance

The Clinical Evaluation B. Achieve normal core temperature. Raise the body temperature and maintain

The Clinical Evaluation B. Achieve normal core temperature. Raise the body temperature and maintain a normal or nearnormal temperature-36°C

The Clinical Evaluation C. Achieve normal systolic blood pressure. Neurologic examination is usually reliable

The Clinical Evaluation C. Achieve normal systolic blood pressure. Neurologic examination is usually reliable with a systolic blood pressure 100 mm Hg.

The Clinical Evaluation D. Perform 1 neurologic examination If a certain period of time

The Clinical Evaluation D. Perform 1 neurologic examination If a certain period of time has passed since the onset of the brain insult to exclude the possibility of recovery, 1 neurologic examination should be sufficient to pronounce brain death.

4 Steps in Determining Brain Death The Clinical Evaluation The Neurologic Assessment

4 Steps in Determining Brain Death The Clinical Evaluation The Neurologic Assessment

The Neurologic Assessment A. Coma Patients must lack all evidence of responsiveness. Eye opening

The Neurologic Assessment A. Coma Patients must lack all evidence of responsiveness. Eye opening or eye movement to noxious stimuli is absent. Noxious stimuli should not produce a motor response other than spinally mediated reflexes.

The Neurologic Assessment B. Absence of Brain Stem Reflex Absence of pupillary response to

The Neurologic Assessment B. Absence of Brain Stem Reflex Absence of pupillary response to a bright light is documented in both eyes. Absence of ocular movements using oculocephalic testing and oculovestibular reflex testing. Absence of corneal reflex. Absence of facial muscle movement to a noxious stimulus. Absence of the pharyngeal and tracheal reflexes.

The Neurologic Assessment C. Apnea Absence of a breathing drive. Breathing drive is tested

The Neurologic Assessment C. Apnea Absence of a breathing drive. Breathing drive is tested with CO 2 Challenge. Prerequisites: 1) normotension 2) normothermia, 3) euvolemia 4) eucapnia (Pa. CO 2 35– 45 mm Hg) 5) absence of hypoxia 6) no prior evidence of CO 2 retention

The CO 2 Challenge Adjust vasopressors to a systolic blood pressure 100 mm Hg.

The CO 2 Challenge Adjust vasopressors to a systolic blood pressure 100 mm Hg. Preoxygenate for at least 10 minutes with 100% oxygen to a Pa. O 2 200 mm Hg. Reduce ventilation frequency to 10 breaths per minute to eucapnia. Reduce positive end-expiratory pressure (PEEP) to 5 cm H 2 O If pulse oximetry oxygen saturation remains 95%, obtain a baseline blood gas

The CO 2 Challenge Disconnect the patient from the ventilator. Preserve oxygenation(e. g. ,

The CO 2 Challenge Disconnect the patient from the ventilator. Preserve oxygenation(e. g. , place an insufflation catheter through the endotracheal tube and close to the level of the carina and deliver 100% O 2 at 6 L/min). Look closely for respiratory movements for 8– 10 minutes. Abort if systolic blood pressure decreases to 90 mm Hg. Abort if oxygen saturation measured by pulse oximetry is 85% for 30 seconds.

The CO 2 Challenge If no respiratory drive is observed, repeat blood gas after

The CO 2 Challenge If no respiratory drive is observed, repeat blood gas after 8 minutes. If respiratory movements are absent and arterial PCO 2 is 60 mm Hg (or 20 mm Hg increase in arterial PCO 2 over a baseline normal arterial PCO 2), the apnea test result is POSITIVE. If the test is inconclusive but the patient is hemodynamically stable during the procedure, it may be repeated for a longer period of time (10– 15 minutes) after the patient is again adequately preoxygenated.

4 Steps in Determining Brain Death The Clinical Evaluation The Neurologic Assessment Ancillary Test

4 Steps in Determining Brain Death The Clinical Evaluation The Neurologic Assessment Ancillary Test

Ancillary Tests In clinical practice, EEG, cerebral angiography, nuclear scan, TCD, CTA, and MRI/MRA

Ancillary Tests In clinical practice, EEG, cerebral angiography, nuclear scan, TCD, CTA, and MRI/MRA are currently used ancillary tests in adults. Ancillary tests can be used when uncertainty exists about the reliability of parts of the neurologic examination or when the apnea test cannot be performed.

“In adults, ancillary tests are not needed for the clinical diagnosis of brain death

“In adults, ancillary tests are not needed for the clinical diagnosis of brain death and cannot replace a neurologic examination. ”

4 Steps in Determining Brain Death The Clinical Evaluation The Neurologic Assessment Ancillary Test

4 Steps in Determining Brain Death The Clinical Evaluation The Neurologic Assessment Ancillary Test Documentation

Documentation Time of death is the time the arterial PCO 2 reached the target

Documentation Time of death is the time the arterial PCO 2 reached the target value (60). In patients with an aborted apnea test, the time of death is when the ancillary test has been officially interpreted.

Mechanism of Cerebral Death Neuronal Injury Neuronal Swelling ICP>MAP is incompatible with life Decreased

Mechanism of Cerebral Death Neuronal Injury Neuronal Swelling ICP>MAP is incompatible with life Decreased Intracranial Blood Flow Increased Intracranial Pressure

Conditions Distinct From Brain Death Persistent Vegetative State Locked-in Syndrome Minimally Responsive State

Conditions Distinct From Brain Death Persistent Vegetative State Locked-in Syndrome Minimally Responsive State

Persistent Vegetative State Normal Sleep-Wake Cycles No Response to Environmental Stimuli Diffuse Brain Injury

Persistent Vegetative State Normal Sleep-Wake Cycles No Response to Environmental Stimuli Diffuse Brain Injury with Preservation of Brain Stem Function

Minimally Responsive Static Encephalopathy Diffuse or Multi-Focal Brain Injury Preserved Brain Stem Function Variable

Minimally Responsive Static Encephalopathy Diffuse or Multi-Focal Brain Injury Preserved Brain Stem Function Variable Interaction with Environmental Stimuli

Locked-in Syndrome Ventral Pontine Infarct n Complete Paralysis n Preserved Consciousness n Preserved Eye

Locked-in Syndrome Ventral Pontine Infarct n Complete Paralysis n Preserved Consciousness n Preserved Eye Movement

Brain Death Neurological Examination Clinical Prerequisites: n Known Irreversible Cause n Exclusion of Potentially

Brain Death Neurological Examination Clinical Prerequisites: n Known Irreversible Cause n Exclusion of Potentially Reversible Conditions ▪ Drug Intoxication or Poisoning ▪ Electrolyte or Acid-Base Imbalance ▪ Endocrine Disturbances n Core Body temperature > 32° C

Brain Death Neurological Examination Coma Absent Brain Stem Reflexes Apnea

Brain Death Neurological Examination Coma Absent Brain Stem Reflexes Apnea

Coma No Response to Noxious Stimuli ▪ Nail Bed Pressure ▪ Sternal Rub ▪

Coma No Response to Noxious Stimuli ▪ Nail Bed Pressure ▪ Sternal Rub ▪ Supra-Orbital Ridge Pressure

Absence of Brain Stem Reflexes Pupillary Reflex Eye Movements Facial Sensation and Motor Response

Absence of Brain Stem Reflexes Pupillary Reflex Eye Movements Facial Sensation and Motor Response Pharyngeal (Gag) Reflex Tracheal (Cough) Reflex

Pupillary Reflex Pupils dilated with no constriction to bright light

Pupillary Reflex Pupils dilated with no constriction to bright light

Eye Movements Occulo-Cephalic Response “Doll’s Eyes Maneuver”

Eye Movements Occulo-Cephalic Response “Doll’s Eyes Maneuver”

Eye Movements Oculo-Vestibular Response “Cold Caloric Testing”

Eye Movements Oculo-Vestibular Response “Cold Caloric Testing”

Facial Sensation and Motor Response Corneal Reflex Jaw Reflex Grimace to Supraorbital or Temporo-Mandibular

Facial Sensation and Motor Response Corneal Reflex Jaw Reflex Grimace to Supraorbital or Temporo-Mandibular Pressure

Apnea Testing Prerequisites ▪ Core Body Temperature > 32° C ▪ Systolic Blood Pressure

Apnea Testing Prerequisites ▪ Core Body Temperature > 32° C ▪ Systolic Blood Pressure ≥ 100 mm Hg ▪ Normal Electrolytes ▪ Normal PCO 2

Apnea Testing 1. Pre-Oxygenation ▪ 100% Oxygen via Tracheal Cannula ▪ PO 2 =

Apnea Testing 1. Pre-Oxygenation ▪ 100% Oxygen via Tracheal Cannula ▪ PO 2 = 200 mm Hg 2. Monitor PCO 2 and PO 2 with pulse oximetry 3. Disconnect Ventilator 4. Observe for Respiratory Movement until PCO 2 = 60 mm Hg 5. Discontinue Testing if BP < 90, PO 2 saturation decreases, or cardiac dysrhythmia observed

Confounding Clinical Conditions Facial Trauma Pupillary Abnormalities CNS Sedatives or Neuromuscular Blockers Hepatic Failure

Confounding Clinical Conditions Facial Trauma Pupillary Abnormalities CNS Sedatives or Neuromuscular Blockers Hepatic Failure Pulmonary Disease

Observations Compatible with Brain Death Sweating, Blushing Deep Tendon Reflexes Spontaneous Spinal Reflexes- Triple

Observations Compatible with Brain Death Sweating, Blushing Deep Tendon Reflexes Spontaneous Spinal Reflexes- Triple Flexion Babinski Sign

Confirmatory Testing Recommended when the proximate cause of coma is not known or when

Confirmatory Testing Recommended when the proximate cause of coma is not known or when confounding clinical conditions limit the clinical examination

Confirmatory Testing EEG Normal Electrocerebral Silence

Confirmatory Testing EEG Normal Electrocerebral Silence

Confirmatory Testing Cerebral Angiography Normal No Intracranial Flow

Confirmatory Testing Cerebral Angiography Normal No Intracranial Flow

Confirmatory Testing Technetium-99 Isotope Brain Scan

Confirmatory Testing Technetium-99 Isotope Brain Scan

Confirmatory Testing MR- Angiography

Confirmatory Testing MR- Angiography

Confirmatory Testing Transcranial Ultrasonography

Confirmatory Testing Transcranial Ultrasonography

Confirmatory Testing Somatosensory Evoked Potentials

Confirmatory Testing Somatosensory Evoked Potentials

 Somatosensory-evoked potentials. Bilateral absence of N 20 -P 22 response with median nerve

Somatosensory-evoked potentials. Bilateral absence of N 20 -P 22 response with median nerve stimulation.

 THANK YOU

THANK YOU

Question 1 Are there patients who fulfil the clinical criteria of brain death who

Question 1 Are there patients who fulfil the clinical criteria of brain death who recover brain function? There is insufficient evidence to determine the minimally acceptable observation period to ensure that neurologic functions have ceased irreversibly.

Question 2 What is an adequate observation period to ensure that cessation of neurologic

Question 2 What is an adequate observation period to ensure that cessation of neurologic function is permanent? There is insufficient evidence to determine the minimally acceptable observation period to ensure that neurologic functions have ceased irreversibly.

Question 3 Are complex motor movements that falsely suggest retained brain function sometimes observed

Question 3 Are complex motor movements that falsely suggest retained brain function sometimes observed in brain death? For some patients diagnosed as brain dead, complex, non– brain-mediated spontaneous movements can falsely suggest retained brain function. Additionally, ventilator autocycling may falsely suggest patient-initiated breathing.

Question 4 What is the comparative safety of techniques for determining apnea? Apneic oxygenation

Question 4 What is the comparative safety of techniques for determining apnea? Apneic oxygenation diffusion to determine apnea is safe, but there is insufficient evidence to determine the comparative safety of techniques used for apnea testing.

Question 5 Are there new ancillary tests that accurately identify patients with brain death?

Question 5 Are there new ancillary tests that accurately identify patients with brain death? Because of a high risk of bias and inadequate statistical precision, there is insufficient evidence to determine if any new ancillary tests accurately identify brain death.

 This update sought to use evidence-based methods to answer 5 QUESTIONS historically related

This update sought to use evidence-based methods to answer 5 QUESTIONS historically related to variations in brain death determination 4 to PROMOTE UNIFORMITY IN DIAGNOSIS.

Historical Perspective 1959 Coma de’passe’ Mollaret and Goulon 1968 Irreversible Coma/Brain Death Harvard Medical

Historical Perspective 1959 Coma de’passe’ Mollaret and Goulon 1968 Irreversible Coma/Brain Death Harvard Medical School Ad Hoc Committee 1981 Uniform Determination of Death Act - President’s Commission for the Study of Ethical Problems in Medicine 1995 American Academy of Neurology Guidelines for the determination of Brain Death 2005 NYS Guidelines for Determining Brain Death

Death “An individual who has sustained either irreversible cessation of circulatory and respiratory functions,

Death “An individual who has sustained either irreversible cessation of circulatory and respiratory functions, or irreversible cessation of all functions of the entire brain, including the brainstem. “ Uniform Determination of Death Act (UDDA)

 A determination of death must be made with accepted medical standards The American

A determination of death must be made with accepted medical standards The American Academy of Neurology (AAN) published a 1995 practice parameter to delineate the medical standards for the determination of brain death.

PRACTICAL (NON–EVIDENCEBASED) GUIDANCE FOR DETERMINATION OF BRAIN DEATH

PRACTICAL (NON–EVIDENCEBASED) GUIDANCE FOR DETERMINATION OF BRAIN DEATH